Devices › Stimulator, neuromuscular, lower back muscles, totally implanted for pain relief
Device brand name · Reactiv8 implantable pulse generator
ReActiv8: medical device reports filed with FDA
435 reports name it, 2021–2026. Manufacturer given most often on reports: Mainstay Medical. Product code QLK.
- 435
- device reports naming the brand
- 0% of all MAUDE reports · about 89 a year
- 174
- reports, 12 months to August 2026
- 118 in the 12 months before
- 44.6%
- classified as malfunction
- 44.6% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 435 reports that name the brand "ReActiv8" (reactiv8 implantable pulse generator), received between August 2021 and August 2026; the manufacturer given most often on reports is Mainstay Medical. Spellings of one product vary from report to report.
174 reports arrived in the 12 months to August 2026, up 47% from 118 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (55.4%) and malfunction (44.6%); across all stimulator, neuromuscular, lower back muscles, totally implanted for pain relief reports (product code QLK) death is recorded in 0% and malfunction in 44.6%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are failure to conduct (41.1%), migration (5.3%) and failure to deliver shock/stimulation (1.4%). The patient problems coded most often are failure of implant, implant pain and post operative wound infection. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 448 reports carrying product code QLK. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Failure to conduct | 179 | 41.1% | 41.3% |
| Migrationthe device moved from where it was placed | 23 | 5.3% | 5.1% |
| Failure to deliver shock/stimulation | 6 | 1.4% | 1.6% |
| Fracturea broken bone | 2 | 0.5% | 0.9% |
| Device damaged by another device | 1 | 0.2% | 0.2% |
| Electrical /electronic property probleman electrical or electronic problem | 1 | 0.2% | 0.2% |
| High impedance | 1 | 0.2% | 0.2% |
| Improper or incorrect procedure or method | 1 | 0.2% | 0.2% |
| Malposition of device | 1 | 0.2% | 0.2% |
| Mechanical problema mechanical problem | 1 | 0.2% | 0.2% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Failure of implant | 185 | 42.5% |
| Implant pain | 123 | 28.3% |
| Post operative wound infection | 23 | 5.3% |
| Wound infectionan infected wound | 8 | 1.8% |
| Impaired healingslow healing | 7 | 1.6% |
| Falla fall | 6 | 1.4% |
| Painpain, site not specified | 5 | 1.1% |
| Bacterial infectiona bacterial infection | 4 | 0.9% |
| Discomfortdiscomfort | 4 | 0.9% |
| Cramp(s) /muscle spasm(s) | 3 | 0.7% |
| Rashskin rash | 3 | 0.7% |
| Skin inflammation/ irritation | 3 | 0.7% |
| Wound dehiscencea wound reopened | 3 | 0.7% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 2 | 0.5% |
| Inflammationinflammation | 2 | 0.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | ReActiv8 | Product code QLK | All MAUDE reports |
|---|---|---|---|
| Reports | 435 | 448 | 26,136,888 |
| Share of that pool | — | 97.1% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 55.4% | 55.4% | 36.2% |
| Classified as malfunction | 44.6% | 44.6% | 62.3% |
| Filed by the manufacturer | 100% | 99.8% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Questions about ReActiv8 reports
How many FDA reports name ReActiv8?
435 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 174 in the latest 12 months.
What kinds of events are reported?
injury (55.4%) and malfunction (44.6%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
failure to conduct (41.1%), migration (5.3%), failure to deliver shock/stimulation (1.4%), fracture (0.5%) and device damaged by another device (0.2%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that ReActiv8 was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.